title: Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
authors.forename: N
authors.initials: N
authors.lastname: Campo
authors.forename: S
authors.initials: S
authors.lastname: Alvarez
authors.forename: S
authors.initials: S
authors.lastname: Borzone
authors.forename: S
authors.initials: S
authors.lastname: Caglieris
authors.forename: P
authors.initials: P
authors.lastname: Zentilin
authors.forename: R
authors.initials: R
authors.lastname: Testa
mesh_terms: D000328:Adult; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D006526:Hepatitis C / Q000378:metabolism*; D006521:Hepatitis, Chronic / Q000378:metabolism*; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000378:metabolism; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009853:Omeprazole / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D008012:Lidocaine; C001173:monoethylglycinexylidide; D006899:Mixed Function Oxygenases; D009853:Omeprazole